Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Iqvia Holdings Inc    IQV

IQVIA HOLDINGS INC

(IQV)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
07/16/2019 07/17/2019 07/18/2019 07/19/2019 07/22/2019 Date
156.57(c) 156.02(c) 157.28(c) 155.85(c) 156.27 Last
715 326 861 420 1 067 406 1 020 098 890 698 Volume
-1.16% -0.35% +0.81% -0.91% +0.27% Change
More quotes
Financials (USD)
Sales 2019 11 017 M
EBIT 2019 2 088 M
Net income 2019 368 M
Debt 2019 10 111 M
Yield 2019 -
Sales 2020 11 803 M
EBIT 2020 2 283 M
Net income 2020 532 M
Debt 2020 9 177 M
Yield 2020 -
P/E ratio 2019 84,7x
P/E ratio 2020 57,1x
EV / Sales2019 3,72x
EV / Sales2020 3,39x
Capitalization 30 823 M
More Financials
Company
IQVIA Holdings Inc., formerly Quintiles IMS Holdings, Inc., provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial... 
More about the company
Surperformance© ratings of Iqvia Holdings Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on IQVIA HOLDINGS INC
08:05aIQVIA : Named to Forbes 2019 List of America's Best Employers for Women
BU
07/09IQVIA : to Announce Second-Quarter 2019 Results on July 24, 2019
BU
07/01IQVIA : Cancer social network app Belong.Life raises $14 million in private fund..
RE
06/26IQVIA : Introduces Patient Centered Endpoints Solution with Transformative eCOA ..
AQ
06/25IQVIA : Introduces Patient Centered Endpoints Solution with Transformative eCOA ..
BU
06/17IQVIA : Chiesi Group Selects IQVIA's OCE Technology Platform to Develop a Custom..
BU
06/13IQVIA : 's OCE Technology Platform Selected by Ferring Pharmaceuticals
BU
06/04IQVIA : 's OCE Technology Platform Selected by Zambon to Establish a Global Mult..
BU
05/30IQVIA : Real World Capabilities and Expertise Support Path to Label Expansion
BU
05/30IQVIA™ INSTITUTE FOR HUMAN DAT : Record Number of Cancer Drugs Launched in..
BU
More news
Sector news : Biotechnology & Medical Research - NEC
11:37aGILEAD SCIENCES : Says Study of GS-6207 Showed HIV Capsid Inhibition Can Lead Vi..
DJ
08:54aGILEAD SCIENCES : Licenses Durect's Saber Technology for Injectable HIV Product
DJ
07/19Gilead Licenses Respiratory, Herpes Antiviral Research Programs From Novartis
DJ
07/17GILEAD SCIENCES : Chief Scientific Officer John McHutchison to Leave
DJ
07/16As steep patent cliff looms, Shionogi moves to develop its own U.S. sales sta..
RE
More sector news : Biotechnology & Medical Research - NEC
Chart IQVIA HOLDINGS INC
Duration : Period :
Iqvia Holdings Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends IQVIA HOLDINGS INC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 21
Average target price 167,16  $
Last Close Price 156,27  $
Spread / Highest target 18,4%
Spread / Average Target 6,97%
Spread / Lowest Target -16,2%
EPS Revisions
Managers
NameTitle
Ari Bousbib Chairman, President & Chief Executive Officer
Jim Berkshire Senior Vice President-Business Operations
Michael R. McDonnell Chief Financial Officer & Executive Vice President
Karl Guenault Chief Information Officer & Senior Vice President
Margaret Keegan President-Clinical Operations
Sector and Competitors
1st jan.Capitalization (M$)
IQVIA HOLDINGS INC34.16%30 740
LONZA GROUP33.10%25 623
CELLTRION, INC.--.--%20 071
INCYTE CORPORATION26.66%17 271
EXACT SCIENCES CORPORATION82.06%14 835
SEATTLE GENETICS, INC.32.49%12 140